References
- Robinson JK: Sun exposure, sun protection, and vitamin D. JAMA 294, 1541–1543, 2005.
- Yusuf N, Irby C, Katiyar SK, and Elmets CA: Photoprotective effects of green tea polyphenols. Photodermatol Photoimmunol Photomed 23(1), 48–56, 2007.
- Cherry CP, and Glucksmann A: The influence of carcinogenic dosage and of sex on the induction of epitheliomas and sarcomas in the dorsal skin of rats. Br J Cancer 25, 544–564, 1971.
- Rajmani RS, Doley J, Singh PK, Kumar R, Singh R, et al.: Induction of skin tumour using DMBA in wistar Rat and histopathological evaluation. Ind J Vet Pathol 35, 217–220, 2011.
- Kakizoe T: Chemoprevention of cancer-focusing on clinical trials. Jpn J Clin Oncol 33(9), 421–442, 2003.
- Chattopadhyay I, Kaushik B, Bandyopadhyay U, and Banerjee1 RK: Turmeric and curcumin: biological actions and medicinal applications. Curr Sci 87, 44–54, 2004.
- Aggarwal BB, Sundaram C, Malani N, and Ichikawa H: Curcumin: the Indian solid gold. Adv Exp Med Bio 59, 51–75, 2007.
- Kotwal GJ: Natural products and moleculartherapy, first international conference. Ann NY Acad Sci 1056, 206–217, 2005.
- Shishodia S, Sethi G, and Aggarwal BB: Curcumin: getting back to the roots. Ann NY Acad Sci 1056, 206–217, 2005.
- Chainani Wu N.: Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma Longa). J Altern Complement Med 9, 161–168, 2003.
- Aggarwal BB, and Shishodia S: Suppression of the nuclear factor-kappa B activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci 1030, 431–41, 2004.
- Chen YR, and Tan TH: Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 17, 173–178, 1998.
- Liu JY, Lin SF, and Lin JK: Inhibitory effect of curcumin on protein kinase C activity induced by 12-O-Tetradeccanolyphorbol -13-acetate in NIH3T3 Cells. Carcinogenesis 14, 857–861, 1993.
- Ravindran J, Prasad S, and Aggarwal B: Curcumin and cancer cells; how many ways can curry kill tumor cell selectively. AAPS J 11, 495–510, 2009.
- Carlson G, Gullberg B, and Hafstrom L: Estimation of liver tumor volume using different formulas-an experimental study in rats. J Can Res Clin Oncol 105, 20–23, 1983.
- Luna LG: Manual of Histological Staining Methods of the Armed Force Institute of Pahtology, 3rd ed. Saunders W.B., Philadelphia, 1972.
- Yu CCW, Fletcher CDM, Newman PL, Goodland JR, Burton JC, et al.: A comparison of proliferating cell nuclear antigen (PCNA) Immunostaining, nucleolar organizer region (AgNOR) staining and histological grading in gastrointestinal stromal tumours. J Pathol 166, 147–152, 1992.
- Crocker J, Boldy D.A, and Egan MJ: How should we count AgNORS? Proposals for a standardized approach. J Pathol 158(3), 185–8, 1989.
- Bravani Shankar TN, Shantha NV, Ramesh HP, Murthy IA, and Murthy VS: Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guinea pigs & monkeys. Ind J Exp Bio 18, 73–75, 1980.
- Nair BC, Saikumar G, and Ram Kumar Paliwal OP: Differential diagnosis of canine cutaneous histiocytoma and canine transmissible venereal tumour by AgNOR and PCNA. Ind J Vet Pathol 30(1), 66–67, 2006.
- Wolf HK, and Dittrich KL: Detection of proliferating cell nuclear antigen in diagnostic histopathology. J Histochem Cytochem 40, 1269–1273, 1992.
- Huang MT, Lou YR, Xie JG, Ma W, Lu YP, Yen P, Zhu BT, Newmark H, and Ho C.T: Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenza. anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. Carcinogenesis 19(9), 1697–1700, 1998.
- Chuang SE, Cheng AL, Lin JK, and Kuo ML: Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. Food Chem Toxicol 38(11), 991–995, 2000.
- Karin M: Nuclear factor-kB in cancer development and progression. Nature 441, 431–436, 2006.
- Sarkar FH, Li Y: NF-kappaB: a potential target for cancer chemoprevention and therapy. Front Biosci 13, 2950–2959, 2008.
- Willscott EN, and Karin M: NF-kB and cancer – identifying targets and mechanisms. Curr Opin Genet Dev 18, 19–26, 2008.
- Greten FR, and Karin M: The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer. Can Lett 206(2), 193–9, 2004.
- Pal S, Bhattacharjee A, Ali A, Mandal NC, Mandal SC, et al.: Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism. J Inflamm 11, 23, 2014.
- Magalska A, Brzezinska A, Bielak-Zmijewska A, Katarzyna P, Grażyna M, et al.: Curcumin induces cell death without oligonucleosomal DNA fragmentation in quiescent and proliferating human CD8+ cells. Acta Biochim Pol 53(3), 531–538, 2006.
- Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, et al.: Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Can Res 10, 6847–6854, 2004.